Overview

Effects of Ulinastatin on Coagulation in High Risk Patients Undergoing Off Pump Coronary Artery Bypass Graft Surgery

Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
Ulinastatin reduce the amount of bleeding and fibrinolysis in high risk patients undergoing off-pump coronary bypass surgery (OPCAB).
Phase:
Phase 4
Details
Lead Sponsor:
Yonsei University
Treatments:
Pharmaceutical Solutions
Urinastatin